CR Bard Looks to Continue to Trade Above its Annual-High Share Price Today
CR Bard (NYSE:BCR) traded today at a new 52-week high of $227.78. So far today approximately 61,000 shares have been exchanged, as compared to an average 30-day volume of 460,000 shares.
C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard markets vascular, urological, oncological, and surgical specialties products.
Over the past year, CR Bard has traded in a range of $166.29 to $227.78 and is now at $227.78, 37% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 0.9%.
CR Bard (NYSE:BCR) is currently priced 11.8% above its average consensus analyst price target of $200.92. The stock should discover initial support at its 50-day moving average (MA) of $202.16 and subsequent support at its 200-day MA of $191.81.
SmarTrend recommended that subscribers consider buying shares of CR Bard on January 25th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $184.50. Since that recommendation, shares of CR Bard have risen 22.0%. We continue to monitor BCR for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows cr bard